Company / Revenue
Evolent Health, Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$483.6M
FY2025
5-year range
$215.1M / $2.6B
FY2021-FY2025
Trend
-81.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $215M in FY2021 to $2.6B in FY2024.
Based on SEC 10-K filings.
$484M in FY2025 with a 5-year CAGR of -12.2%.
Declined from $2.0B to $484M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +17.6%
- 5-Year CAGR
- -12.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -12.2%, indicating a declining trend.
- In FY2025, revenue decreased 81.1% year-over-year.
- Peak revenue was recorded in FY2024.
- Lowest revenue in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $483.6M | -81.1% |
| FY2024 | $2.6B | +30.1% |
| FY2023 | $2.0B | +561.1% |
| FY2022 | $297.1M | +38.1% |
| FY2021 | $215.1M | -76.7% |
| FY2020 | $924.6M | +34.6% |
| FY2019 | $687.1M | +9.6% |
| FY2018 | $627.1M | +44.2% |
| FY2017 | $434.9M | +71.1% |
| FY2016 | $254.2M | +162.4% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026